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Abstract
A plethora of deep learning models have been developed for the task of Alzheimer’s dis-
ease classification from brain MRI scans. Many of these models report high performance,
achieving three-class classification accuracy of up to 95%. However, it is common for these
studies to draw performance comparisons between models that are trained on different
subsets of a dataset or use varying imaging preprocessing techniques, making it difficult to
objectively assess model performance. Furthermore, many of these works do not provide
details such as hyperparameters, the specific MRI scans used, or their source code, making
it difficult to replicate their experiments. To address these concerns, we present a com-
prehensive study of some of the deep learning methods and architectures on the full set
of images available from ADNI. We find that (1) classification using 3D models gives an
improvement of 1% in our setup, at the cost of significantly longer training time and more
computation power, (2) with our dataset, pre-training yields minimal (< 0.5%) improve-
ment in model performance, (3) most popular convolutional neural network models yield
similar performance when compared to each other. Lastly, we briefly compare the effects
of two image preprocessing programs: FreeSurfer and Clinica, and find that the spatially
normalized and segmented outputs from Clinica increased the accuracy of model prediction
from 63% to 89% when compared to FreeSurfer images.
1. Introduction
Alzheimer’s disease (AD) is a degenerative brain disease and the most common cause of
dementia. It is a burdensome and costly disease that affects 5.5 million people in the United
States. The total value of care provided to AD patients is estimated to be around $250
billion a year (Association et al., 2017).
The symptoms of AD include memory loss, challenges in planning, difficulty completing
simple tasks, and decline in other cognitive skills that often lead to a dependency on external
care, which takes a toll on both the family of the individual with AD, as well as society as
a whole.
The disease is characterized by the degeneration of specific nerve cells, presence of
neuritic plaques outside the neurons, and the accumulation of neurofibillary tangles inside
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Alzheimer’s Disease Classification Using MRI Scans
the neurons (McKhann et al., 1984), where the latter two proteins lead to cell death by
interfering with various functions of the cell (Association et al., 2017). As a result, brains
of people with advanced AD show inflammation, dramatic shrinkage from cell loss, and
widespread debris from dead or dying neurons (Association et al., 2017).
While no cure exists for the disease yet, there is consensus on the need and benefit
for early diagnosis of AD. For example, an overwhelming percentage (80%) of older adults
wish to know as early as possible if they have AD (Dale et al., 2008), and early diagnosis
may help caregivers of AD patients feel more competent in caring for the patients, as well
as increasing the possibility that the caregiver can involve the patient in making medical,
financial, legal, and care decisions (de Vugt and Verhey, 2013). Furthermore, Weimer and
Sager (2009) used Monte Carlo cost-benefit analysis to suggest potential social and financial
benefits of early detection.
Diagnosis of AD is typically done with a comprehensive evaluation of the patient, which
may include tests of memory, problem solving, and attention, as well as brain scans us-
ing computed tomography (CT), magnetic resonance imaging (MRI), or positron emission
tomography (PET) scans.
Recently, machine learning techniques, specifically deep learning, show great potential
in aiding the diagnosis of AD using MRI scans. A variety of neural network architectures
have been proposed, some operate on 2D images (Hon and Khan, 2017) (Billones et al.,
2016) (Sarraf et al., 2017), while others operate on 3D MRI scans (Wang et al., 2018)
(Hosseini-Asl et al., 2016) (Payan and Montana, 2015). Because of the relatively small
number of available MRI scans, many proposed architectures (Payan and Montana, 2015)
(Hosseini-Asl et al., 2016) also incorporate an auto-encoder architecture with tied weights
to pre-train the model on a reconstruction task before the classification task to prevent
over-fitting on the data.
However, while there is a sizable number of studies on this topic, for people who wish
to utilize a discriminitive MRI feature extractor for other downstream AD-related tasks, it
is still difficult to glean insights that would be helpful for this task. For example, it is not
clear how much performance is gained by using a 3D convolutional neural network (CNN)
to process the MRI, which has a high computation cost, compared to using a simple 2D
model and processing only one slice, or multiple slices of the MRI. It is also not clear how
much pre-training the model helps with raising the performance of the model, as Gupta
et al. (2013), Payan and Montana (2015), Hosseini-Asl et al. (2016) have done. Finally, it
is also not clear how much the various model architectures contribute to the high accuracy
that various authors have claimed in their paper.
In this study, we explore the aforementioned variables one must consider when selecting
a discriminative CNN setup for AD classification, 1) the difference in performance between
using 2D and 3D models; 2) pre-training the model on reconstruction task before training
it on the classification task; and 3) the performance gain from using model X versus model
Y.
2. Related Work
The idea of using computers to assist in the diagnosis of AD has been around before the
current wave of enthusiasm for neural networks. Plant et al. (2010) used a feature selection
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algorithm to achieve 92% accuracy in a binary classification of AD (Alzheimer’s disease)
versus HC (Healthy Control). Jha et al. (2017) used a dual-tree complex wavelet transform
to extract features (DTCWT) from the MRI scans, performed principle component analysis
(PCA) to reduce the dimension of the extracted features, and a feed-forward neural network
to classify between AD and HC individuals.
Ever since Krizhevsky et al. (2012) won the ImageNet challenge with a seven-layer con-
volutional neural network, surpassing the previous winner by a large margin of 10%, the
computer vision community has mainly shifted from using hand-crafted features with sup-
port vector machines (SVM) or feed-forward neural networks, to large, end-to-end trainable
neural networks with many layers.
Gupta et al. (2013) trained a sparse auto-encoder on both natural images and MRI
images to learn a set of bases or filters. The filters were then convolved with the target
MRI to produce a set of features, which were then down-sampled using max-pooling before
fed into a feed-forward network for classification. Similarly, Payan and Montana (2015)
trained a sparse auto-encoder on randomly selected patches from the MRI scans to learn the
features. They also used max-pooling to reduce the size of the features before introducing
them into a feed-forward network.
More recently, Hon and Khan (2017) used the image entropy of each slice to decide
which of the slices of the MRI scans to use. They then fed the slice through a pre-trained
2D VGG-16 network (Simonyan and Zisserman, 2014), as well as Inception V4 network
(Szegedy et al., 2015), to obtain the final result.
Wang et al. (2018) used DenseNet (Huang et al., 2017) and ensemble methods to classify
the entire 3D MRI scan, leading to a new state-of-the-art three-class (Alzheimer versus Mild
Cognitive Impairment versus Cognitively Normal) classification accuracy of 97.19%. Their
study showed that around 2.5% increase in accuracy was attributed to applying ensemble
method, which falls in-line with other studies that employed the method.
3. Methods
In this section, we detail the setup we used for this study, including the acquisition and
preprocessing of the data, and the model architectures we use in our comparison. Figure 1
provides an overview of the various components our study will cover.
3.1. Data Acquisition
For this study, we obtained MRI scans from the Alzheimer’s Disease Neuroimaging Initiative
(ADNI) 1. Specifically, we are using MRI scans with the description “MPR; GradWarp; B1
Correction; N3”, which we will henceforth refer to as “preprocessed” scans, as well as
the FreeSurfer post-processed MRI scans with the description “FreeSurfer Cross-Sectional
Processing brainmask” in the ADNI database. A total of 3415 “preprocessed” scans and
3177 FreeSurfer post-processed scans were obtained from the website.
1. ADNI Website: http://adni.loni.usc.edu/
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Figure 1: An overview of the pipeline of our experiments. The “preprocessed” MRI scans
from ADNI are processed by Clinica, then used for both 2D and 3D classification. The
FreeSurefer scans from ADNI are used directly for 3D classification.
3.2. Data Preprocessing
Due to the prominence of extraneous parts of the head that are captured in MRI scans, which
can potentially intorduce noise in the network, most studies use FSL2 and/or Statistical
Parameteric Mapping (SPM)3 for the preprocessing of the MRI scans. FSL provides brain
extraction and tissue segmentation functionality, and SPM realigns, spatially normalizes,
and smoothes the scans.
For our experiments, we used the Clinica software platform4 developed by the ARAMIS
Lab5, which supports FSL, SPM, FreeSurfer, as well as a few other technologies. We are
using the t1-volume pipeline, which is a wrapper of the “segmentation”, “run dartel”, and
“normalize to mni space” routines implemented in SPM.
The inputs to the Clinica pipeline were the “preprocessed” scans from ADNI, and the
outputs of the Clinica pipeline include spatially normalized gray matter, white matter,
and cerebrospinal fluid segmentation maps, as well as a brain extraction output similar to
the FreeSurfer post-processed scans from ADNI’s dataset, with a difference being that the
Clinica outputs are spatially normalized.
Furthermore, we extract 2D slices from fixed indices for each view of the spatially
normalized brain extraction output. The indices were chosen based on visual prominence of
the hippocampus of the brain. Specifically, they were the 52nd slice of axial view, the 58th
slice of sagittal view, and the 92nd slice of coronal view. We also experimented with using
2. FSL: https://fsl.fmrib.ox.ac.uk/fsl/fslwiki/FSL
3. SPM: https://www.fil.ion.ucl.ac.uk/spm/
4. Clinica: http://www.clinica.run
5. Aramis Lab: www.aramislab.fr
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(a) The axial, coronal, and sagittal view of the “preprocessed” scans.
(b) The axial, coronal, and sagittal view of the FreeSurfer post-processed scans.
(c) The 52nd axial, 92nd coronal, and 58th sagittal view of the brain extraction outputs
from Clinica, which we used for 2D classification.
Figure 2: Slices from “preprocessed” scans, FreeSurfer post-processed scans, and the specific
slices we use for 2D classification.
neighboring slices for classification. Figure 2 shows the 2D slices of the brain extraction
output by Clinica.
3.2.1. Demographics
After processing the “preprocessed” scans with Clinica, we obtained 2023 sets of scans.
Table 1 shows the demographics of the FreeSurfer post-processed scans, and Table 2 shows
the demographics of the outputs from the Clinica pipeline. Note that the output from
Clinica had fewer scans because some were lost in the process due to unknown reasons.
5
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Class
No. of
subjects
No. of
scans
Sex Age
Male Female Mean Std. Dev
AD 326 928 185 141 74.8 7.3
MCI 219 1408 141 78 75.1 5.3
CN 217 982 118 99 75.6 7.3
Table 1: Demographics for the FreeSurfer post-processed scans from ADNI’s website.
Class
No. of
subjects
No. of
scans
Sex Age
Male Female Mean Std. Dev
AD 199 586 106 93 75.4 7.3
MCI 237 827 144 93 76.1 5.4
CN 169 610 81 88 75.4 7.1
Table 2: Demographics for the output scans of the Clinica pipeline. Note that some of the
scans were lost in the process due to unknown reasons.
3.2.2. Training / Validation / Testing Split
To evaluate the performance of our models, we split the data into a training set, validation
set, and testing set, with a ratio of 6:2:2. We save the model with the lowest validation loss,
and use that to obtain the final accuracy on the test set.
AD MCI CN Total
Clinica
Train 330 330 330 990
Validation 110 110 110 330
Test 110 110 110 330
FreeSurfer
Train 351 351 351 1053
Validation 117 117 117 351
Test 117 117 117 351
Table 3: Data distribution between the three classes (AD versus MCI versus CN) and
training, validation, and testing folds for both FreeSurfer post-processed scans and Clinica
outputs.
For each run, we split the data into three classes: (AD, MCI, CN). We then perform
shuffling on each of the splits. The first N scans of each class are used to create a balanced
dataset, where N is the size of the smallest class. We then split each of the classes into
training, validation, and testing set. See Section .1 in Appendix A for details on the
procedure, and Table 3 for the final distribution for both the Clinica and FreeSurfer images.
Many previous works such as Wang et al. (2018), Hosseini-Asl et al. (2016), and Sarraf
et al. (2017), performed ten-fold cross-validation as a way of measuring the performance
of their model. We decided to deviate from this setup because we are not performing
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hyperparameter search, and therefore require an extra set of data for final evaluation so we
can use the validation set to guide early-stopping. To compensate for the reduced number
of possible combinations of data that we can train, validate, and test in one run, we utilize
the aforementioned shuffling scheme, and run each experiment four to six times to obtain
a good randomized sample over the training, validation, and testing set. All of the 2D
experiments were run six times, but we were only able to run the 3D experiments four
times each due to the significantly longer time and greater computation power required.
3.3. 2D Convolutional Neural Network Models
For classifying 2D slices of MRIs, we use an 18-layer residual network (He et al., 2016a), a
16-layer VGG network (Simonyan and Zisserman, 2014), a 121-layer DenseNet (Huang et al.,
2017), and the Inception V3 architecutre (Szegedy et al., 2016). We believe that our selection
of networks is representative of the most popular network architectures currently being used
by the computer vision community, and the designs of many of the more complex networks
we have come across, such as Wang et al. (2018)’s 3D DenseNet, borrow architectural ideas
from these networks.
The models we selected are pre-built models from the PyTorch model zoo, and unless
specified otherwise, the weights of the models are initialized from weights pre-trained on
the ImageNet dataset. The last layer of each of the models was replaced with a linear layer
that reduced the dimension of the extracted features of the convolutional layers down to
three, each corresponding to one of three classes (AD/MCI/CN).
3.4. 3D Convolutional Neural Network Models
Because there are no pre-built 3D models available, we built a 16-layer (Table 4) and 22-layer
(Table 5) CNN model following the architectural designs of the residual network (He et al.,
2016a). Specifically, we used the “bottleneck” configuration to reduce the number of filters
in the inner layer of each residual block (He et al., 2016a), and the “full pre-activation”
layout (He et al., 2016b) for the residual blocks. The layout of each residual block can be
found in Table 6.
3.4.1. Convolutional Autoencoder
Similar to Hosseini-Asl et al. (2016) and Payan and Montana (2015), we added a decoder to
our 22-layer CNN by reversing the weights of the CNN to form an autoencoder. Specifically,
a simplified formula for the operation is described in Equation 1, where X is the input
matrix, W is the weight matrix, f is an activation function, Y is a matrix representing the
feature extracted from X, Xˆ is a reconstruction of X by the network, and · denotes dot
product.
Y = f(W T ·X)
Xˆ = f(W · Y ) (1)
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In Channel Out Channel Kernel Size Stride
convolution layer 1 32 3 1
residual block 32 32 — —
convolution layer 32 64 3 2
residual block 64 64 — —
convolution layer 64 128 32
residual block 128 128 — —
convolution layer 128 256 3 2
convolution layer 256 512 3 2
convolution layer 512 512 3 2
convolution layer 512 512 3 1
linear layer 32768 3 — —
Table 4: Architecture and hyperparameters for the 16-layer 3D residual network.
In Channel Out Channel Kernel Size Stride
convolution layer 1 32 3 1
residual block 32 32 — —
convolution layer 32 64 3 2
residual block 64 64 — —
convolution layer 64 128 3 2
residual block 128 128 — —
convolution layer 128 256 3 2
residual block 256 256 — —
convolution layer 256 512 3 2
residual block 512 512 — —
convolution layer 512 512 3 2
convolution layer 512 512 3 1
linear layer 32768 3 — —
Table 5: Architecture and hyperparameters for the 22-layer 3D residual network.
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In Channel Out Channel Kernel Size Stride
Batch Norm — — — —
ReLU — — — —
Convolution Layer n n/2 1 1
Batch Norm — — — —
ReLU — — — —
Convolution Layer n/2 n/2 3 1
Batch Norm — — — —
ReLU — — — —
Convolution Layer n/2 n 1 1
Table 6: The layers for the residual block used in our 3D residual network. n is the number
of input channels.
3.5. Optimization Process
3.5.1. Reconstruction Task
To train the convolutional autoencoder on the reconstruction task, we minimize the mean
squared error (MSE), its formulation is shown in Equation 2, where X is the input matrix
(the MRI scan), Xˆ is obtained from the formulation shown in Equation 1, n is the number
of MRI scans, and m is the number of features (or voxels) in the scan.
MSE =
1
n
n∑
i=1
m∑
j=1
(Xij − Xˆij)2 (2)
Following Hosseini-Asl et al. (2016) and Payan and Montana (2015), we apply a sparsity
constraint β to the hidden representation Y , giving us the end-to-end formulation of the
objective for the reconstruction task, shown in Equation 3. We exclude the formulation in
Equation 3 for the weight decay (L2 Regularization) for brevity.
Loss =
1
n
n∑
i=1
m∑
j=1
(Xij − Xˆij)2 + β ∗ Yij (3)
3.5.2. Classification Task
For the classification task, we minimize the cross-entropy loss between the predicted proba-
bility distribution of the correct label and the ground truth distribution. The objective has
the following formulation, shown in Equation 4, where pˆ is a vector of probability distribu-
tion predicted by the model, l is index of the correct class (e.g. 0 for AD, 1 for MCI, 2 for
CN), and pˆl and pˆj are the lth and jth element of pˆ, respectively.
Loss(pˆ, l) = − log( exp(pˆl)∑#classes
j=1 exp(pˆj)
) (4)
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3.5.3. Training
We ran all of our experiments for 100 epochs. The weights that led to the lowest validation
loss were saved and later used to make predictions on the test set. We chose to save the
model with the lowest validation loss instead of the lowest validation accuracy because
the validation loss captures the divergence between the predicted distribution and the true
distribution, whereas accuracy may or may not capture this.
For hardware, hyperparameters, and other information on training, see Section .2 in
Appendix A.
4. Results
4.1. Evaluation Approach
The goal of this study is to answer three queries one may have when deciding among the
numerous proposed architectures as feature extractors for other AD-related downstream
tasks. Specifically, we are looking to understand the performance gain, if any, from 1)
using a 2D model on a slice of the scan versus 3D model on the entire MRI scan, 2) pre-
training the model on the reconstruction task before training it on the classification task,
and 3) different choices of models and architectures.
We attempt to provide insight into these three questions by keeping all other variables
constant, such as preprocessing pipelines, variations in data distribution, hyperparameters
for training and testing.
All of the experiments were performed at least four times, and no more than six times,
due to resource constraints. To calculate the reported validation accuracy, we take the
highest validation accuracy that we encounter in every run, and take the mean as the final
validation accuracy. For the test accuracy. we simply take the mean of all of the test
accuracy across the runs.
4.2. 2D versus 3D Models
For this comparison, we evaluated the performance of 2D ResNet-18 pre-trained on Im-
ageNet, and our own 3D ResNet-22 pre-trained on extra MRI scans left over from class
balancing (see Section 3.2.2). The 2D ResNet-18 is trained on the coronal slice of the gray
matter map from Clinica, and the 3D ResNet-18 is trained on the entire gray matter map.
From Table 7, we can conclude that there is a performance gain of close to 1% from
utilizing 3D models instead of similar 2D models, which may be desirable if accuracy is
crucial in the target application. However, there is a large cost of going from 2D to 3D,
namely the time required to train the model, and the large amount of GPU memory required
to fit the image and model. See Section .2 in Appendix A for more training information.
Model name Validation Accuracy Test Accuracy
2D gray matter (coronal) 89.5± 1.8% 87.4± 2.0%
3D gray matter - w/ pre-train 90.3± 1.2% 88.5± 1.7%
Table 7: A comparison between 2D ResNet-18 pre-trained on ImageNet and 3D ResNet-22
pre-trained on MRI scans. There is a slight performance advantage with the 3D model.
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4.3. Pre-training versus No Pre-Training
For this comparison, we evaluate the effects of pre-training on the model’s ability to learn
and the final accuracy. Table 8 contains the final accuracy, where there is little evidence to
suggest that the model is unable to learn without pre-training, or that pre-training leads
to better performance.
Model Validation Accuracy Test Accuracy
gray matter - no pre-train 90.1± 1.0% 88.9± 2.0%
gray matter - w/ pre-train 90.3± 1.2% 88.5± 1.7%
gray matter + CSF + white matter - no pre-train 91.0± 0.7% 89.2± 1.9%
gray matter + CSF + white matter - w/ pre-train 90.4± 0.8% 88.9± 2.0%
Table 8: Comparison between models with pre-training versus models without pre-training.
The results show negligible difference in performance, with a difference in mean accuracy
of less than < 0.5%.
.
4.4. Model Comparisons
For this comparison, we look at how much impact the model architecture influences the
performance of the model, by comparing four popular 2D networks. Table 9 shows a com-
parison of the results.
Again, we observe little difference between the various architectures, suggesting that the
commonly used architectures should be able to perform well on the task.
Model name Validation Accuracy Test Accuracy
ResNet-18 (coronal) 89.2± 2.5% 87.5± 1.1%
DenseNet121 (coronal) 90.0± 1.3% 88.8± 1.9%
InceptionNet V3 (coronal) 89.1± 1.7% 88.6± 1.4%
VGG19 bn (coronal) 89.1± 1.6% 88.1± 2.7%
Table 9: Three-class classification accuracy of the 2D models.
4.5. FreeSurfer versus Clinica
We performed an additional set of experiments to gain some insight into the difference
in performance between using FreeSurfer data from the ADNI website, which were skull-
stripped but not spatially normalized, and white matter, gray matter, and cerebrospinal
fluid maps from the Clinica pipeline.
We used the same 3D 16-layer ResNet that we built for both experiments, and found
a significant difference in accuracy between the two sets, highlighting the importance and
advantage of using the Clinica pipeline. See Table 10 for the accuracy comparison.
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Preprocessing Pipeline Validation Accuracy Test Accuracy
FreeSurfer 77.2± 0% 63.5± 0%
Clinica 91.4± 1.2% 89.2± 0.4%
Table 10: Comparison between FreeSurfer data, which does not have spatial normalization,
among other preprocessing procedures, and the Clinica output data. Both experiments were
run with our 3D 16-layer ResNet.
5. Discussion
By comparing the various setups, we have come to the conclusion that: (1) there is a
slight improvement of about 1% in performance by using a 3D model over a 2D model,
(2) the advantage of pre-training the model on MRI scans before training it end-to-end for
classification was not noticeable, (3) all of the current popular 2D CNN architectures had
similar performance.
For (1), we leave the reader with the caveat that training a 3D model requires signifi-
cantly more time and computation power, and the extra 1% gain in accuracy may not be
worth the cost.
For (2), while we have concluded that pre-training does not aid our model in achieving
higher accuracy, we are not rebutting the previous studies over their claim that pre-training
helped. We have to consider that we have more data available to us, likely enough to a
point where pre-training may no longer be necessary.
For (3), our results suggest that the features of the model, such as densely connected
layers or Inception modules, do not contribute as much to the performance in the task of AD
classification as previous studies (Wang et al., 2018)(Hon and Khan, 2017) had suggested.
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Appendix A.
.1. Data Splitting Methodology
Suppose we have 20 scans, where 7 are labeled as AD, 5 are labeled as MCI, and 8 are
labeled as CN. We first shuffle each of the three splits, then take the first 5 scans from
each of the class sets, where 5 = min(7, 5, 8), resulting in a final dataset size of 15 from the
three classes. We then split each of the three sets into training, validation, and testing sets,
resulting in nine total sets. Lastly, we combine the training, validation, and testing sets
across all three classes to create a final training set of 9 scans, validation set of 3 scans, and
testing set of 3 scans.
.2. Additional Training Information
.2.1. Hardware and Training Time
For training the 3D models, we used pairs of NVIDIA Tesla M40 GPUs with 24GB of
memory. We were able to fit two images on each of the GPUs, bringing our maximum
possible batch size to 4. The training time for the experiments ranged from 12-14 hours for
the Clinica preprocessed images, to 24-26 hours for the FreeSurfer images. The significantly
longer training time was mostly due to the larger file size, which led to slow network IO
and longer computation time.
For training the 2D models, we used NVIDIA Titan X GPUs with 12GB of memory. We
used a batch size of 16, which was not dictated by memory limit, but rather by intuition, as
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smaller batch size intuitively leads to better generalization with adaptive learning algorithms
such as Adam. The training time for most 2D models completed within 2 hours.
.2.2. Hyperaparameters
For all of the 3D models, we used Adam optimizer for both the reconstruction task and the
classification task. For the reconstruction task, we used a learning rate of 0.001 and weight
decay (also known as L2 regularization) of 0.0001, as well as 0.0003 for β, the sparsity
constraint parameter. For the classification task, we use a learning rate of 0.001 and weight
decay (L2 regularization) of 0.0001.
For the 2D models, we used Adam optimizer for the classification task, with learning
rate set to 0.001 and weight decay set to 0.01 for ResNet18, and learning rate set to 0.0001
and weight decay set to 0.01 for Inception V3, VGG-16, and DenseNet.
The aforementioned hyperparameters are chosen from past experience, as they generally
work well for Adam. To keep the experiments consistent, no additional hyperparameter
search was performed, with the exception of training Inception V3, VGG-16, and DenseNet,
where we lowered the learning rate from 0.001 to 0.0001 because the models were having
difficulty training with the higher learning rate.
Table 13 lists each of the training hyperparameters we used for the different models and
tasks.
.3. Tables
Model name Validation Accuracy Test Accuracy No. MRI Data
ResNet-18 (coronal) 89.2± 2.5% 87.5± 1.1% 2023
ResNet-18 (sagittal) 88.65± 1.9% 88.0± 2.5% 2023
ResNet-18 (axial) 89.7± 3.2% 87.5± 2.5% 2023
ResNet-18 (coronal) gray matter only 89.5± 1.8% 87.4± 2.0% 2023
DenseNet121 (coronal) 90.0± 1.3% 88.8± 1.9% 2023
InceptionNet V3 (coronal) 89.1± 1.7% 88.6± 1.4% 2023
VGG19 bn (coronal) 89.1± 1.6% 88.1± 2.7% 2023
Billones et al. (2016) — 91.9% 900
Hon and Khan (2017) VGG-16 — 92.3± 2.4% 200
Hon and Khan (2017) Inception V4 — 96.25± 1.2% 200
Table 11: Three-class classification accuracy of our 2D models, as well as a few other studies
for comparison.
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Model Val Accuracy Test Accuracy # Subjects
gray matter - no pre-train 90.1± 1.0% 88.9± 2.0% 605
gray matter - w/ pre-train 90.3± 1.2% 88.5± 1.7% 605
gray matter + CSF + white matter - no pre-train 91.0± 0.7% 89.2± 1.9% 605
gray matter + CSF + white matter - w/ pre-train 90.4± 0.8% 88.9± 2.0% 605
Wang et al. (2018) (w/o ensemble) — 94.7% 833
Hosseini-Asl et al. (2016) — 94.8% 210
Jain et al. (2019) — 95.7% 150
Payan and Montana (2015) — 89.4% 755
Khvostikov et al. (2018) (MRI only) — 85.4% 200
Table 12: Three-class classification accuracy for our 3D models, as well as a few other
studies for comparison. Our models in this table is the 22-layer residual network, which
was mentioned in Section 3.4.
task optimizer learning rate weight decay sparsity param
ResNet-16 (3D) R Adam 0.001 0.0001 0.0003
ResNet-22 (3D) R Adam 0.001 0.0001 0.0003
ResNet-16 (3D) C Adam 0.001 0.0001 —
ResNet-22 (3D) C Adam 0.001 0.0001 —
ResNet-18 (2D) C Adam 0.001 0.01 —
Inception V3 (2D) C Adam 0.0001 0.01 —
VGG-16 (2D) C Adam 0.0001 0.01 —
DenseNet (2D) C Adam 0.0001 0.01 —
Table 13: The training hyperparameters used for all of the models. In the task column, R
denotes reconstruction, and C denotes classification.
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